KU Leuven-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2024

  1. The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis

    Pediatric Blood and Cancer

2021

  1. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis

    Critical Reviews in Oncology/Hematology, Vol. 161

2017

  1. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

    Journal of Pediatrics, Vol. 189, pp. 72-78.e3

2016

  1. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

    RMD Open, Vol. 2, Núm. 1

  2. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2013

  1. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years

    Pediatric Blood and Cancer, Vol. 60, Núm. 2, pp. 175-184

  2. MS/MS networking guided analysis of molecule and gene cluster families

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 28